Hong Kong Spinocerebellar Ataxias Registry
Learn more about:
Related Clinical Trial
Treatment of Transcranial Alternating Current Stimulation(tACS)on Cerebellar Ataxia
Repetitive Transcranial Magnetic Stimulation in SCA3 Patients
STRIDES – a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3
Neuropsychiatry and Cognition in SCA3/MJD
Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD – BIGPRO Study Astrocytes
Clinical Effects of Oral Trehalose In Patients With Spinocerebellar Ataxia 3
Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3
Hong Kong Spinocerebellar Ataxias Registry
Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia
Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
Clinical Trial Readiness for SCA1 and SCA3
Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD
Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
Identification of Biomarkers in Spinocerebellar Ataxia 3
Machado-Joseph Disease in Israel
Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3